Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multicenter randomized controlled trial of adalimumab versus standard therapy in refractory uveitis
2006-001732-53Phase 2Terminated
- Sponsor
- Heidelberg University Hospital
- Start
- Jun 2006
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial of adalimumab in uveitis (2 arms), sponsored by Heidelberg University Hospital. Started Jun 2006; status: terminated.
02
Drugs
03
Conditions
uveitis
Beyond the preview
Go deeper on 2006-001732-53.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-001732-53.